Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Wolfgang Hübl"'
Autor:
Michael Schwarz, Caroline Schwarz, Lukas Burghart, Nikolaus Pfisterer, David Bauer, Wolfgang Hübl, Mattias Mandorfer, Michael Gschwantler, Thomas Reiberger
Publikováno v:
PLoS ONE, Vol 18, Iss 8, p e0290352 (2023)
IntroductionLiver cirrhosis accounts for considerable morbidity and mortality worldwide and late presentation limits therapeutic options. We aimed to assess characteristics of patients with liver cirrhosis at the time of first presentation and during
Externí odkaz:
https://doaj.org/article/7768ae03d7c148b38c41a6b4902b9168
Autor:
Susanne Claudia Gruber, Matthias Karl Freynhofer, Martin Willheim, Thomas Werner Weiss, Florian Egger, Wolfgang Hübl, Kurt Huber
Publikováno v:
Platelets, Vol 30, Iss 4, Pp 506-512 (2019)
Long-term evidence shows an increased risk of cardiovascular events in the morning hours and recent studies in aspirin-treated patients have shown increased platelet reactivity at the end of the dosing interval. Similar pharmacodynamic analyses of ad
Externí odkaz:
https://doaj.org/article/ac5c2a6113e840929849ea86ac81f3a3
Publikováno v:
European Journal of Translational Myology, Vol 28, Iss 1 (2018)
Physical medicine therapies are often used in treating widespread musculoskeletal disorders, such as neck and low back pain. Herbal cataplasms containing rubefacient substances, such as Cayenne pepper, or galenic preparations like Munari cataplasm ar
Externí odkaz:
https://doaj.org/article/257ba9546784405a809997d3460c9e1e
Autor:
Christoph Buchta, Stephan W. Aberle, Franz Allerberger, Bernhard Benka, Irene Görzer, Andrea Griesmacher, Wolfgang Hübl, Wolfgang Huf, Stylianos Kapiotis, Mathias M. Müller, Erich Neuwirth, Elisabeth Puchhammer-Stöckl, Lukas Weseslindtner, Jeremy Camp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ff74deee8577bc75eedebb219758022
https://doi.org/10.2139/ssrn.4401712
https://doi.org/10.2139/ssrn.4401712
Autor:
Caroline A. Heckman, Arnold Bolomsky, Heinz Ludwig, Stefan Kubicek, Niklas Zojer, Jo Caers, Andrej Besse, Juho J. Miettinen, Helene Breid, Alina Malyutina, Wolfgang Hübl, Martin Schreder, Alun Owen Parsons, Lenka Besse, Jing Tang, Christoph Driessen, J. Thomas Hannich, Julia Huber, Stefanie Fellinger, Kristaps Klavins
Publikováno v:
Blood Advances. 5:4125-4139
Antiapoptotic Bcl-2 family members have recently (re)emerged as key drug targets in cancer, with a tissue- and tumor-specific activity profile of available BH3 mimetics. In multiple myeloma, MCL-1 has been described as a major gatekeeper of apoptosis
Autor:
Caroline Schwarz, David Jm Bauer, Livia Dorn, Mathias Jachs, Lukas Hartl, Heidemarie Holzmann, Nikolaus Pfisterer, Barbara Hennlich, Florian Mayer, Ralf Schmidt, Astrid Voll-Glaninger, Wolfgang Hübl, Martin Willheim, Karin Köhrer, Sonja Jansen-Skoupy, Sabine Tomez, Walter Krugluger, Christian Madl, Michael Schwarz, Leonard Brinkmann, Lukas Burghart, Gerhard Weidinger, Florian Riedl, Hermann Laferl, Christoph Wenisch, Abdelrahman Aburaia, Christian Sebesta, Daniela Schmid, Thomas Reiberger, Andreas Maieron, Michael Gschwantler
Publikováno v:
Journal of Hepatology. 77:S545
Autor:
Arnold Bolomsky, Wolfgang Hübl, Martin Willheim, Adalbert Weißmann, Niklas Zojer, Heinz Ludwig, Antonio Palumbo, Alberto Rocci, Veronique Fritz, Karin Schlangen, Ercan Müldür, Daniel Heintel, Stefano Spada
Publikováno v:
American Journal of Hematology. 92:269-278
Immunomodulatory drugs (IMiDs) are a cornerstone in the treatment of multiple myeloma (MM), but specific markers to predict outcome are still missing. Recent work pointed to a prognostic role for IMiD target genes (e.g. CRBN). Moreover, indirect acti
Autor:
Art Branstrom, Kathrin Stangelberger, Jo Caers, Niklas Zojer, Arnold Bolomsky, Elodie Duray, Christina Pfeiffer, Margaux Lejeune, Louise Vrancken, Marla Weetall, Heinz Ludwig, Helene Breid, Joséphine Muller, Wolfgang Hübl, Martin Willheim
Publikováno v:
British journal of haematologyReferences. 190(6)
Future progress in the treatment of multiple myeloma (MM) requires both the characterisation of key drivers of the disease and novel, innovative approaches to tackle these vulnerabilities. The present study focussed on the pre-clinical evaluation of
Autor:
Florian Egger, Alexander Geppert, Veronika Bruno, Wolfgang Hübl, Martin Willheim, Serdar Farhan, Matthias K. Freynhofer, Miklos Rohla, Thomas W. Weiss, Maximilian Tscharre, Johann Wojta, Kurt Huber
Publikováno v:
Europe PubMed Central
Publons
Publons
Background Increased platelet turnover and high platelet reactivity are associated with short-term major adverse cardiovascular events (MACE) after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) or stable coronary artery d
Publikováno v:
Leukemia & Lymphoma. 57:2516-2525
Immune suppression is a hallmark of multiple myeloma (MM), but data on soluble factors involved in the fate of immune effector cells are limited. The CXCR3-binding chemokine monokine induced by interferon-gamma (MIG/CXCL9) has been associated with tu